Angiodynamic Inc
ANGO
Market Cap$245.13M
Close$
$-0.18
103% downside
Current Fair Value
103% downsideOvervalued by 103% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $245.13 Million |
|---|---|
| Enterprise Value | $166.68 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-4.81 |
| Beta | 1.12 |
| Outstanding Shares | 40,054,533 |
| Avg 30 Day Volume | 774,863 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.27 |
|---|---|
| PEG | -0.07 |
| Price to Sales | 0.75 |
| Price to Book Ratio | 1.21 |
| Enterprise Value to Revenue | 0.51 |
| Enterprise Value to EBIT | -5.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Angiodynamic Inc
CEO: James Clemmer AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines in...